MET and cancer: Nine TNBC samples presented more than one somatic cancer driver, including five, that revealed two cancer drivers, represented by one dual-role gene (TP53) in concomitance with one TSG (NF1 or PTPN13), or one oncogene (MET), or one dual-role gene (NOTCHor1 or GATA3) (Table 4, Table 5).